Documentation Information Medication Dispensing 
pharmacy mentor
OCTOBER 22, 2024
This technology is reforming the management of prescriptions, enhancing the accuracy of medication dispensing, streamlining communication with healthcare providers, and allowing pharmacists to devote more time to patient care. In traditional settings, communicating such critical information can take hours or even days.
Proxsys Rx
APRIL 4, 2024
Optimizing visibility allows for clinicians to avoid duplication of efforts, and ensure safety and efficacy — with full laboratory data, and other relevant information (i.e., allergies, medication history, etc), easily available. Fortunately, those steps tend to be the least burdensome in the process.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Proxsys Rx
AUGUST 22, 2023
Optimizing visibility allows for clinicians to avoid duplication of efforts, and ensure safety and efficacy — with full laboratory data, and other relevant information (i.e., allergies, medication history, etc), easily available. Fortunately, those steps tend to be the least burdensome in the process.
Proxsys Rx
DECEMBER 22, 2023
Optimizing visibility allows for clinicians to avoid duplication of efforts, and ensure safety and efficacy — with full laboratory data, and other relevant information (i.e., allergies, medication history, etc), easily available. Fortunately, those steps tend to be the least burdensome in the process.
FDA Law Blog: Biosimilars
OCTOBER 17, 2023
Background The Breakthrough Devices Program, established under section 515B of the Federal Food, Drug, and Cosmetic Act (FD&C Act), is a voluntary program for certain medical devices and device-led combination products. By Philip Won & Lisa M. Wysa, see here ) and addiction (e.g., reSET-O, see here , here ).
Expert insights. Personalized for you.
52 
Let's personalize your content